Fig. 1

Serum Anti-oxidant capacity evaluation of CON, KLF, and AGP treatments. A superoxide dismutase (SOD) activity evaluation of CON, KLF, and AGP treatments. B glutathione peroxidase (GSH-PX) activity evaluation of CON, KLF, and AGP treatmentsC, malondialdehyde (MDA) content evaluation of CON, KLF, and AGP treatments. CON control treatment; KLF kudzu-leaf flavonoids supplement treatment, and AGP the antibiotic supplement (Aureomycin) treatments